Skip to main content

MoonLake Immunotherapeutics

MLTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001821586

In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in MoonLake Immunotherapeutics as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
33
+10 vs. Q3 2022
Shares held
37.7M
+960.7K (+2.6%) vs. Q3 2022
Total value
$396.4M
+$105.5M (+36.3%) vs. Q3 2022
New holders
14
6 more added
Sold out
4
7 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 33 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 1 institutionQ2 2022: 23 institutionsQ3 2022: 24 institutionsQ4 2022: 33 institutionsQ1 2023: 43 institutionsQ2 2023: 83 institutionsQ3 2023: 118 institutionsQ4 2023: 125 institutionsQ1 2024: 113 institutionsQ2 2024: 110 institutionsQ3 2024: 108 institutionsQ4 2024: 115 institutionsQ1 2025: 135 institutionsQ2 2025: 129 institutionsQ3 2025: 133 institutionsQ4 2025: 130 institutionsQ1 2026: 147 institutionsQ2 2026: 172 institutions
Value heldQ4 2022: $396.4M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $7.26MQ2 2022: $190.1MQ3 2022: $291.4MQ4 2022: $396.4MQ1 2023: $853.3MQ2 2023: $2.87BQ3 2023: $3.22BQ4 2023: $3.55BQ1 2024: $3.01BQ2 2024: $2.71BQ3 2024: $3.13BQ4 2024: $3.42BQ1 2025: $2.35BQ2 2025: $2.77BQ3 2025: $269.6MQ4 2025: $743.1MQ1 2026: $1.18BQ2 2026: $1.43B
Institutions holding MLTX and their total value by quarter
QuarterHoldersValue
Q2 2026172$1.43B
Q1 2026147$1.18B
Q4 2025130$743.1M
Q3 2025133$269.6M
Q2 2025129$2.77B
Q1 2025135$2.35B
Q4 2024115$3.42B
Q3 2024108$3.13B
Q2 2024110$2.71B
Q1 2024113$3.01B
Q4 2023125$3.55B
Q3 2023118$3.22B
Q2 202383$2.87B
Q1 202343$853.3M
Q4 202233$396.4M
Q3 202224$291.4M
Q2 202223$190.1M
Q1 20221$7.26M
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q3 2022.

Institutions holding MLTX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
BVF Inc21,751,284$228.4M9.64%00.0%Unchanged
Cormorant Asset Management, LP6,065,001$63.7M4.28%00.0%Unchanged
Citadel Advisors LLC2,886,092$30.3M0.04%+200,155+7.5%Added
TCG Crossover Management, LLC1,000,000$10.5M1.85%00.0%Unchanged
Polar Capital Holdings Plc876,377$9.20M0.07%+876,377New
Price T Rowe Associates Inc822,601$8.64M0.00%−46,787−5.4%Reduced
BlackRock Inc.741,758$7.79M0.00%−740.0%Reduced
Great Point Partners LLC642,566$6.75M1.39%+150,566+30.6%Added
RTW Investments, LP500,000$5.25M0.11%00.0%Unchanged
AXA S.A.405,284$4.26M0.02%+405,284New
Braidwell LP381,120$4.00M0.13%+381,120New
Tekla Capital Management LLC300,000$3.15M0.12%00.0%Unchanged
Tang Capital Management LLC245,714$2.58M0.37%−13,340−5.1%Reduced
Balyasny Asset Management LLC217,999$2.29M0.01%+118,125+118.3%Added
FMR LLC185,500$1.95M0.00%−633,677−77.4%Reduced
Citigroup Inc166,317$1.75M0.00%+7,230+4.5%Added
Acuta Capital Partners, LLC93,500$981.8K0.60%+93,500New
UBS Group AG73,388$770.6K0.00%−2,276−3.0%Reduced
Jefferies Financial Group Inc.67,654$710.4K0.01%+67,654New
TD Asset Management Inc67,312$706.8K0.00%00.0%Unchanged
Barclays PLC55,952$587.5K0.00%+40,768+268.5%Added
JPMorgan Chase & Co44,844$471.0K0.00%+44,844New
Cheyne Capital Management (UK) LLP32,129$337.4K0.60%+32,129New
Morgan Stanley27,365$287.3K0.00%+24,265+782.7%Added
SVB Financial Group16,173$169.8K0.46%+16,173New
Meridian Wealth Management, LLC15,000$154.3K0.02%−12,000−44.4%Reduced
Virtu Financial LLC14,395$151.0K0.02%+14,395New
Two Sigma Investments, LP12,385$130.0K0.00%+12,385New
Renaissance Technologies LLC11,609$122.0K0.00%+11,609New
Geode Capital Management, LLC11,451$120.0K0.00%+11,451New
Goldman Sachs Group Inc10,110$106.2K0.00%−100−1.0%Reduced
Bank of America Corp7,900$83.0K0.00%+7,900New
Royal Bank of Canada76$1.00K0.00%+76New
Point72 Asset Management, L.P.0$00.00%−335,000−100.0%Sold out
Ghost Tree Capital, LLC0$00.00%−300,000−100.0%Sold out
Monashee Investment Management LLC0$00.00%−191,945−100.0%Sold out
Alps Advisors Inc0$00.00%−20,144−100.0%Sold out
Jefferies Group LLC––––Not filed